Sciences of Pharmacy
Open Access

Sciences of Pharmacy

sciphar@etflin.com (Managing Editor)
Preclinical and clinical drug developmentDrug deliveryPharmaceutical formulationPharmacodynamicsPharmacokineticsDrug metabolismPharmacogeneticsGene-based therapyCell-based therapyProtein-based therapyDrug classesDrug nomenclatureDrug-drug interactionAdverse drug reactionDrug toxicityPharmacovigilancePharmacoepidemiologyPharmacoeconomicsClinical pharmacy

Official Affiliation

Affiliation logo

Volume 1 Issue 2

Showing 5 Articles

RESEARCH ARTICLE

  • Pharmacophore Modeling and Molecular Docking of Flavonoid Derivatives in Abelmoschus manihot Against Human Estrogen Receptor Alpha of Breast Cancer
    research article

    Pharmacophore Modeling and Molecular Docking of Flavonoid Derivatives in Abelmoschus manihot Against Human Estrogen Receptor Alpha of Breast Cancer

    Recky Patala, Viani Anggi

    Tamoxifen is the most commonly used anti-estrogen adjuvant therapy for estrogen receptor-positive breast cancer. However, it is associated with an increased risk of some serious side effects, such as uterine cancer, stroke, and pulmonary embolism. The flavonoid compounds in the leaves of A. manihot inhibited the growth of 4T1 breast cancer cells at a CTC50 concentration of 185.06 μg/ml. Therefore, this study aims to examine the molecular interactions and pharmacophore modeling based on the interaction of 4-OHT with human ER, followed by the molecular docking of the flavonoid derivatives with human ERα. The molecular docking simulations and 3D structure-based pharmacophore models were used to identify the molecular interactions of flavonoid derivatives in A. manihot on estrogen receptors (ERα) (PDB ID: 3ERT). The results showed that the binding energies of the flavonoid derivatives in isorhamnetin and isoquercitrin were -8.68 kcal/mol and -8.75 kcal/mol, respectively. This compound also interacted with Arg394 and Glu353 important amino acid residues in the ERα-binding pocket. Meanwhile, the pharmacophore fit scores of isorhamnetin and isoquercitrin were 82.36% and 84.91%, respectively. The flavonoid derivatives in A. manihot had pharmacophore fit resulting from the 4-OHT complex with ER, and therefore they had potential as ERα antagonists. Out of the 10 flavonoid derivatives, isorhamnetin and isoquercitrin showed the best docking scores and could be used as candidates for new anti-breast cancer drugs with antagonistic activity against ERα.

    Sciences of Pharmacy

    3 Oct 2022
    7 pages
  • research article

    Antibiotic Use in Diabetes Mellitus Patients with Gangrene at Abdoel Wahab Sjahranie Samarinda Hospital

    Jessy Amalia Pratama Beta, Octaviana Maria Simbolon, Maria Elvina Tresia Butar-butar

    Gangrene is one of the complications of diabetes mellitus. Along with the rising prevalence of diabetes mellitus (DM), the prevalence of gangrene and necrosis manifestations such as ulcers and infections will ascend. The selection of appropriate antibiotics is critical in infection therapy. Inappropriate use of antibiotics will result in antibiotic resistance. Therefore, this research aims to overview demographic, clinical characteristics, antibiotic use profiles, and antibiotic-related problems for DM patients with gangrene at the Abdoel Wahab Sjahranie Samarinda Hospital. The study was retrospective research and was conducted in July-December 2021. Twenty-one patients met the inclusion criteria, and demographic data showed that most patients were men 57% (n=11), and most age was 39-59 years (57%, n=12). The longest period of suffering from gangrene was 6-10 years (14%, n=3). The most common length of hospitalization was 8-14 days, as reported by 52 percent (n=11) of patients, and the most common duration of antibiotic use was ten days, as reported by 86 percent (n=18) of patients. A single-used antibiotic was ceftriaxone (19%, n=4) patients. The most used antibiotic combination was ceftriaxone and metronidazole (81%, n=17). Fourteen patients used antibiotics appropriately in dosage, route, and frequency. Four patients were unsuitable for the benefit of antibiotics in terms of antibiotic type, and three patients were unsuitable for antibiotic use in terms of duration of administration.

    Sciences of Pharmacy

    20 Oct 2022
    5 pages
  • research article

    Profile of Intravenous Preparation Mixing in Patients at the Regional General Hospital's Intensive Care Unit Abdoel Wahab Sjahranie Samarinda

    Dwi Ayu Riningsih, Octaviana Maria Simbolon, Maria Elvina Tresia Butar-butar

    Compatibility is one of the quality characteristics of intravenous (IV) preparations that influences the effectiveness of patient therapy in the intensive care Unit (ICU). This study aimed to determine the compatibility profile of IV medication formulations given to ICU patients. This prospective observational research was undertaken on patients in the ICU of a private hospital in Samarinda. The data on the intravenous combination of drugs were compared in this study utilizing the ASHP Injectable Drug Information literature 21st edition, Injectable drug guide, and Manual Book. Injectable Drug Mixing was published in 2009 as a resource for determining the compatibility of intravenous formulations. Using certain criteria, combinations of intravenous medicines and their solvents are classed as compatible (C), incompatible (I), and unknown (U). The ICU had 25 patients, 15 of whom were male, and 10 of them were female. There is no mixing of drug compounds containing incompatible solvents. All drugs were carried out with 100% compatible solvents. The limited information related to the compatibility and stability of these intravenous preparations encourages continuous monitoring of the patient's condition and drug levels.

    Sciences of Pharmacy

    15 Oct 2022
    5 pages
  • research article

    Evaluation of Mixed Intravenous Preparation in Patients at the Hospital "X" Samarinda's Intensive Care Unit (ICU)

    Christy Putri Tari, Octaviana Maria Simbolon, Maria Elvina Tresia Butar-butar

    Mixing intravenous preparation, especially in patients' intensive care unit (ICU) at the hospital, requires special attention on their higher medication errors, such as nosocomial infection and incompatibility drugs. The personnel, facilities, infrastructure, and mixing process must be carefully considered when preparing sterile mixtures. This study aims to calculate the percentage of suitability for the mixing process for intravenous preparations based on the Basic Guidelines for Dispensing Sterile Preparations, Guidelines for Injectable and Cytostatic Drugs in 2009, and the Handbook of Injectable Drugs Edition 16th for Intensive Care Unit (ICU) patients at the hospital “X” Samarinda. The research is descriptive research using sheets of observational data collection. The research subjects are mixing facilities, infrastructure, and procedures. We found as many as 215 processes of mixing intravenous preparations in the ICU, showing that nurses carried out 100% of compounding, 100% of the infrastructure did not have a clean room, LAF, and pass box, 53% carried out the mixing process according to procedures, and physical quality tests. Drug preparations follow the Handbook of Injectable Drugs Edition 16th. The preparations produced are clear and free of foreign particles.

    Sciences of Pharmacy

    9 Oct 2022
    6 pages
  • research article

    Knowledge Level of OTC and OTC Limited Drugs Use for Self-medication in the Community of Tondo Village, Mantikulore District, Central Sulawesi, Indonesia

    Ainun Jariya, Andi Atirah Masyita, Ririen Hardani

    Self-medication, the act of treating oneself without a doctor's prescription, carries inherent risks, as evidenced by the substantial 85.85% engagement in this practice among Central Sulawesi residents in 2021, according to the Indonesia Central Bureau of Statistics. This study, conducted in Tondo Village from August to November 2021 with a sample of 386 respondents, aimed to illuminate the characteristics of those partaking in self-medication. Noteworthy findings included a majority of female respondents (52.3%), aged 26-35 (24.4%), engaged in household work (31.1%), and with a high school education background (46.4%). Common minor illnesses addressed through self-medication encompassed fever (15.54%), ulcers (7.46%), coughs (15.54%), flu (18.91%), diarrhea (2.85%), headaches (1.30%), and allergies (0.78%). Examining over-the-counter (OTC) and OTC limited medicines, prevalent choices included paracetamol for fever (33.16%), antacids for ulcers (75.70%), Komix® for coughs (28.8%), Mixagrib® for flu (36.99%), Entrostop® for diarrhea (70.00%), Ibuprofen for headaches (100%), and CTM for allergies (100%), with 61.46% procured from pharmacies or drug stores. The selection of medications often stemmed from personal or familial usage history (84.46%), and 47.15% opted for self-medication to economize on treatment costs. Encouragingly, the study found that 75.09% of respondents exhibited good knowledge regarding the use of OTC and OTC-limited drugs for self-medication, underscoring the importance of ongoing education and awareness for responsible self-medication practices in the community.

    Sciences of Pharmacy

    19 Oct 2022
    6 pages

Journal Key Facts

Publishing Fee (APC)

IDR 1100000

Open Access License

CC BY 4.0

Language

English

Abstracting & Indexing
SintaCAS

Overview

Sciences of Pharmacy (SciPhar) is a peer-reviewed open-access journal of pharmacy owned and published by ETFLIN. We offer a platform and place for researchers and intellectuals, especially the youth, to share their insights and works. SciPhar accepts original article, reviews, mini-review, book-review, technical note, case report, case series, clinical trial, opinion/perspective, conference proceeding, and pictorial essay. Author may submit or suggest another type of scientific manuscript. Sciphar publishes 4 issues a year. Sciences of Pharmacy is affiliated with Faculty of Pharmacy, Universitas Islam Sultan Agung.

Authors from countries other than Indonesia are not charged a publication fee until further notice.

Published 4 issues a year (March, June, September and December) with a continuous publishing model — accepted articles are immediately assigned to the active issue.
Eligible Article Types: Case Report, Case Series, Clinical Trial, Editorial, Letter to Editor, Meta Analysis, Mini Review, Opinion/Perspective, Research Article, Review, Technical Note
Current Issue

Latest Articles

Recently published research articles, review papers, and technical notes from the current volume of the journal.

  • research article

    Griess Assay Evaluation of Nitric Oxide Scavenging by a Multi-Extract Emulgel for Topical Steroid Withdrawal

    Wahyu Bachtiar, Tyssa Mariyana, Nurul Hidayatri, Bheta Sari Dewi, Ayu Werawati

    Topical steroid withdrawal (TSW) is an iatrogenic dermatosis following prolonged topical corticosteroid use, with limited non-steroidal alternatives. This study developed a multi-extract emulgel containing Andrographis paniculata, Tinospora cordifolia, Curcuma longa, and Piper nigrum and screened its nitric oxide (NO)-scavenging activity. Standardized ethanolic extracts were incorporated into eight emulgels (F1–F8) using a 2³ full factorial design, varying A. paniculata (3–5%), T. cordifolia (4–6%), and C. longa (4–6%) with P. nigrum fixed at 10%. Physical characterization showed homogeneous oil-in-water emulgels with pH 5.26–5.90, spreadability 6.7–6.8 cm, and viscosity 12,560–17,120 cP. IC₅₀ values for all formulations exceeded the highest tested concentration (100 µg/mL) without reaching the concentration-response curve plateau, and are reported as > 100 µg/mL compared to 18.48 µg/mL for ascorbic acid. Descriptive ranking placed F4 first, followed by F7 and F8. Exploratory factorial analysis indicated that C. longa levels and the A. paniculata × T. cordifolia interaction drove IC₅₀ variation, showing that higher extract loading did not enhance activity. Because this cell-free assay reflects only direct chemical NO scavenging, findings are strictly preliminary and descriptive. Future validation requires independent runs across an expanded concentration range capturing the full upper plateau. F4 is tentatively proposed as the lead formulation for confirmatory testing and subsequent stability, cell-based, and in vivo studies.

    Sciences of Pharmacy

    1 Nov 2026
    16 pages
  • review

    Solid Lipid Nanoparticles as Delivery Systems for Plant-Derived Phytochemicals in Cancer Therapy: A Systematic Review

    Ade Abiyyatun Mahdiyyah, Mazaya Fadhila, Moh. Firman Irwanto, Ayu Rana Esadini, Wafa Wafa, Alfa Frista Arta, Ira Novita Sari

    Solid lipid nanoparticles (SLNs) have been investigated as lipid-based delivery systems to improve the solubility, stability, bioavailability, and delivery of plant-derived phytochemicals to tumors for cancer therapy. However, the available evidence remains heterogeneous and predominantly preclinical. This systematic review aimed to evaluate the formulation strategies, physicochemical characteristics, and therapeutic applications of phytochemical-loaded SLNs in cancer therapy. The review followed the PRISMA 2020 guidelines. Original research articles in English investigating phytochemical-loaded SLNs for cancer therapy were included. Data on formulation composition, preparation methods, physicochemical properties, drug release, in vitro anticancer activity, pharmacokinetics, biodistribution, and in vivo antitumor efficacy were extracted. Risk of bias was assessed using the SYRCLE tool for animal studies and an adapted checklist for in vitro studies. Thirty one articles were included in the qualitative synthesis. Most SLNs had particle sizes in the nanoscale range, approximately 50-350 nm, with encapsulation efficiencies of 43-99% and sustained-release profiles. Encapsulation generally improved cellular uptake and in vitro cytotoxicity in several cancer models. However, evidence of improved bioavailability, active tumor targeting, and in vivo antitumor efficacy remained limited and heterogeneous. Surface modification enhanced cellular uptake or organ accumulation in some studies, but validated tumor-specific targeting was not consistently demonstrated. Overall, phytochemical-loaded SLNs demonstrate potential as delivery platforms; however, clinical translation requires standardized formulations, robust in vivo studies, comprehensive safety evaluations, and clinical trials.

    Sciences of Pharmacy

    7 Nov 2026
    19 pages
  • research article

    Solid Preservative Preparation from Decolorized Ethanolic Extract of Ginggiang (Leea aequata L.): A 90-Day Subchronic Toxicity Study in Rats

    Purwaniati Purwaniati, Rahmana Emran Kartasasmita, Maria Immaculata Iwo, Muhamad Insanu

    Natural preservatives derived from medicinal plants require a thorough safety evaluation before they can be used in food. Ginggiang has traditionally been used by the Kuta indigenous community in Ciamis, West Java, Indonesia, to preserve palm sap; however, its safety profile has not been evaluated. In this study, a solid preservative preparation was developed from the decolorized ethanolic extract of ginggiang leaves (SPP-ED), and its safety profile was assessed after repeated oral administration. The study focused on subchronic oral toxicity and identified the target organs affected by repeated exposure to SPP-ED. In a 90-day experiment, both male and female Wistar rats received SPP-ED at doses of 45, 150, or 1500 mg/kg body weight per day. Satellite groups were included to evaluate recovery. Various parameters, including behavioral, hematological, biochemical, urinalysis, organ index, and histopathological evaluations, were systematically analyzed. No mortality was observed during the study. The results showed that subchronic exposure to SPP-ED had sex-specific effects: female rats experienced renal alterations, characterized by changes in urinalysis, elevated blood urea nitrogen and creatinine levels, and signs of tubular degeneration. In contrast, male rats exhibited pulmonary changes, including an increased lung-to-body weight ratio, alveolitis, and fibrosis. The D1 dose (45 mg/kg body weight/day) was the lowest dose at which potentially adverse histopathological changes were observed; however, a definitive NOAEL and LOAEL could not be established. Further studies using lower dose levels are warranted to better characterize the dose-response relationship and establish the NOAEL and LOAEL of SPP-ED.

    Sciences of Pharmacy

    2 Nov 2026
    13 pages
  • research article

    Polypharmacy and Potentially Inappropriate Medications (PIMs) in Older Adults with Cardiometabolic Disease: A STOPP/START Criteria-Based Analysis

    Yeni Farida, Rizki Amalia Taufany

    Potentially inappropriate medications (PIMs) are a common issue in older adults. Older adults often require multiple medications to manage cardiometabolic disease. This study aimed to identify potentially inappropriate medications and potential inappropriate omissions using STOPP/START criteria in older adult patients with cardiometabolic disease. We conducted an observational analytical study using retrospective data at a secondary care teaching hospital in Sukoharjo, Central Java. We included older adult patients admitted to the inpatient wards between January and June 2022. The prescriptions were analyzed using the STOPP/START Criteria 2016. The Chi-square test analysis was performed to examine the association between the number of drugs and the occurrence of PIMs. We included 97 geriatric inpatients. All patients received at least 5 drugs during each admission, 35.06% were classified as having hyperpolypharmacy. Among the 97 patients, 36.08% had PIM prescriptions, and 29.89% had PPOs. There was a statistically significant association between the number of drugs and PIMs in older adults. Compared with patients receiving > 10 medications, those receiving 5–10 medications had lower odds of PIM use (OR 0.409, 95% CI 0.173–0.969; p = 0.040). These findings highlight high medication burden as an important marker for targeted medication review in geriatric inpatients, particularly those with cardiometabolic multimorbidity.

    Sciences of Pharmacy

    31 Oct 2026
    10 pages
  • research article

    Comparison of PEG 4000 and 6000 in Solid Dispersion of Tadalafil Prepared by Melting Method

    Moh. Firman Irwanto, Arif Budi Setianto, Ade Abiyyatun Mahdiyyah, Maratun Shoaliha, Amzal Mortin Andas, Ashar Prima, Indah Puspitasari, Andi Tenri Nurwahidah, Fauziah H Wada

    Tadalafil is a BCS Class II drug with very low aqueous solubility, limiting its oral bioavailability. Solid dispersion technology using polyethylene glycol (PEG) is an effective strategy to enhance solubility. This study aimed to compare the effectiveness of PEG 4000 and PEG 6000 as carriers in amorphous solid dispersions of tadalafil prepared by the melting method. Solid dispersions were prepared at weight ratios (tadalafil:polymer) of 1:1, 1:2, 1:3, and 1:4 for both PEG 4000 and PEG 6000 using the fusion technique (70 °C). The formulations were characterized by Powder X-Ray Diffraction (PXRD), Differential Scanning Calorimetry (DSC), and Fourier Transform Infrared (FTIR) spectroscopy. Solubility studies were conducted in distilled water and phosphate buffer (pH 6.8) and analyzed via a validated HPLC method. Solid dispersions with PEG 6000 at a 1:3 ratio (F7) exhibited the highest solubility enhancement, reaching 16.08 ± 0.6 µg/mL in water. For PEG 4000, the 1:2 ratio (F2) was optimal (8.20 ± 1.3 µg/mL). PXRD and DSC analyses confirmed the transformation of crystalline tadalafil into an amorphous state within the polymer matrix. FTIR spectra indicated shifts in N-H and C=O bands, suggesting hydrogen bond formation. In conclusion, PEG 6000 produced a superior solid dispersion for tadalafil compared to PEG 4000. The primary mechanism is the formation of an amorphous system stabilized by hydrogen bonding. This study provides a formulation basis for improving the oral delivery of tadalafil.

    Sciences of Pharmacy

    2 Nov 2026
    9 pages